Cargando…
Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis
BACKGROUND: The CXCL12/CXCR4 axis transactivates HER2 and promotes intraosseous tumor growth. To further explore the transactivation of HER2 by CXCL12, we investigated the role of small GTP protein G(αi2) in Src and HER2 phosphorylation in lipid raft membrane microdomains and the significance of CXC...
Autores principales: | Conley-LaComb, M. Katie, Semaan, Louie, Singareddy, Rajareddy, Li, Yanfeng, Heath, Elisabeth I., Kim, Seongho, Cher, Michael L., Chinni, Sreenivasa R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093938/ https://www.ncbi.nlm.nih.gov/pubmed/27809841 http://dx.doi.org/10.1186/s12943-016-0552-0 |
Ejemplares similares
-
PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
por: Conley-LaComb, M Katie, et al.
Publicado: (2013) -
A novel cross-talk between CXCR4 and PI4KIIIα in prostate cancer cells.
por: Sbrissa, Diego, et al.
Publicado: (2018) -
TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model
por: Semaan, Louie, et al.
Publicado: (2019) -
Adaptor proteins mediate CXCR4 and PI4KA crosstalk in prostate cancer cells and the significance of PI4KA in bone tumor growth
por: Govindarajan, Barani, et al.
Publicado: (2023) -
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
por: Wong, Donald, et al.
Publicado: (2014)